# Clementia Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/clementia-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Montreal, Canada
- Website: www.clementiapharma.com
- Total disclosed funding: $33M
- Latest round: Series A (Jan 5, 2015)
- Investors on record: 2

## About

Founded in 2011 and based in Montreal, Quebec, Clementia Pharmaceuticals Inc. is a biopharmaceutical company that develops treatments for patients suffering from ultra-rare bone disorders and other diseases. They are developing palovarotene, an investigational retinoic acid receptor gamma (RAR?) selective agonist, for the treatment of individuals with fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and dry eye disease.

## Funding rounds

- Series A, Jan 5, 2015, $10M — OrbiMed Advisors, BDC Capital
- Series A, Jan 9, 2014, $23M — OrbiMed Advisors, BDC Capital

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series A